HRT — Hormone Replacement Therapy
Hormone replacement therapy may be considered for individuals experiencing symptoms associated with hormonal change or deficiency. Treatment is personalised following clinical assessment, with appropriate discussion of potential benefits, risks, alternatives and monitoring.
TRT — Testosterone Replacement Therapy
Testosterone replacement therapy is a medical treatment that may be considered for appropriately assessed men with confirmed testosterone deficiency and relevant clinical symptoms. Assessment should include appropriate history, examination and laboratory testing, followed by ongoing monitoring where treatment is prescribed.
Peptide Therapy (Research Only)
Peptides are short chains of amino acids that act as signalling molecules in the body. Growth hormone secretagogues, including ipamorelin, CJC-1295 and sermorelin, stimulate the pituitary gland to release the body’s own growth hormone and have attracted interest for potential effects on body composition, recovery, sleep, skin quality, energy and healthy ageing. However, these compounds are currently research grade and are not licensed medicines for human use, with much of the evidence coming from laboratory, animal and small clinical studies rather than large, long-term trials. While early research is encouraging, individual responses vary and factors such as age, hormonal status, health conditions and medications are important. Quality, sourcing and handling are also critical. As this is a developing field, an informed, individualised approach is essential. Speak with us to understand what the current research shows and whether it may be relevant to you.
EBOO - Extracorporeal Blood Oxygenation and Ozonation
EBOO (Extracorporeal Blood Oxygenation and Ozonation), also known as EBO₂, is a doctor-led blood-processing treatment in which blood is circulated outside the body and exposed to a controlled oxygen–ozone mixture before being returned to the patient. The treatment is being investigated for its potential effects on redox balance, inflammatory pathways and cellular responses, and is used within some integrative and longevity medicine programmes. While early research has reported potential benefits in selected conditions, robust evidence remains limited and treatment protocols are not yet standardised. EBOO should therefore be considered an adjunct to, rather than a replacement for, established medical care, with patient selection, monitoring and treatment frequency individualised following medical assessment.
Comprehensive Hormone and Gut Testing
Comprehensive hormone panels, such as urine-based metabolite testing, may be considered alongside standard blood tests to show how hormones are processed and cleared, and how cortisol patterns across the day may relate to stress and sleep. Gut microbiome testing may also be relevant, as gut bacteria influence how hormones such as oestrogen are metabolised and recirculated. For patients on HRT or TRT, these tests may help clinicians individualise treatment and support monitoring. Results are interpreted alongside symptoms and other investigations, and are not diagnostic on their own.
